| Interpretive Data: |
Refer to report.
Refer to Statement B under Testing Information at http://www.aruplab.com.
|
| Note: |
This assay detects mutations in codons 12, 13, and 61. If KRAS is not detected, BRAF codon 600 Mutation Detection will be performed. Additional charges apply.
|
| CPT Code(s): |
88381 Microdissection; 83907 Lysis; 83898 x2 Amplification; 83904 x2 Sequencing; 83912 Interpretation and report, if reflexed, add 83898 Amplification; 83904 Sequencing; 83912 Interpretation and report - Additional CPT code modifiers may be required for procedures performed to test oncologic or inherited disorders.
|
Cross References: |
Cetuximab (Erbitux) (KRAS Mutation Detection with Reflex to BRAF Codon 600 Mutation Detection)
, Panitumumab (Vectibix) (KRAS Mutation Detection with Reflex to BRAF Codon 600 Mutation Detection)
|